FLT3 Inhibitors in Mutant FLT3 AML

被引:0
|
作者
Stone, Richard M. [1 ]
Garcia, Jacqueline [1 ]
机构
[1] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave,D2053, Boston, MA 02215 USA
关键词
ACUTE MYELOID-LEUKEMIA; NORMAL CYTOGENETICS; CONTROLLED-TRIAL; SORAFENIB; YOUNGER; PLACEBO;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S36 / S37
页数:2
相关论文
共 50 条
  • [41] Sorafenib displays antiproliferative effects in FLT3 mutated as well as in wildtype FLT3 AML cells
    Schult, C.
    Sekora, A.
    Krohn, S.
    Schaab, C.
    Godl, K.
    Freund, M.
    Junghanss, C.
    ONKOLOGIE, 2011, 34 : 78 - 78
  • [42] Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition
    Brown, P
    Meshinchi, S
    Levis, M
    Alonzo, TA
    Gerbing, R
    Lange, B
    Arceci, R
    Small, D
    BLOOD, 2004, 104 (06) : 1841 - 1849
  • [43] FLT3 tyrosine kinase inhibitors
    Levis, M
    Small, D
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 82 (02) : 100 - 107
  • [44] Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
    Weisberg, Ellen
    Choi, Hwan Geun
    Barrett, Rosemary
    Zhou, Wenjun
    Zhang, Jianming
    Ray, Arghya
    Nelson, Erik A.
    Jiang, Jingrui
    Moreno, Daisy
    Stone, Richard
    Galinsky, Ilene
    Fox, Edward
    Adamia, Sophia
    Kung, Andrew L.
    Gray, Nathanael S.
    Griffin, James D.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (09) : 2468 - 2477
  • [45] Incorporating a FLT3 inhibitor into AML therapy
    Levis, M. J.
    Small, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] Inhibition of FLT3 in AML: a focus on sorafenib
    Antar, A.
    Otrock, Z. K.
    El-Cheikh, J.
    Kharfan-Dabaja, M. A.
    Battipaglia, G.
    Mahfouz, R.
    Mohty, M.
    Bazarbachi, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 (03) : 344 - 351
  • [47] FLT3 inhibitors tested in LAM
    Rousselot, Philippe
    HEMATOLOGIE, 2007, 13 (01): : 15 - 15
  • [48] Mechanisms of resistance to FLT3 inhibitors
    Chu, S. Haihua
    Small, Donald
    DRUG RESISTANCE UPDATES, 2009, 12 (1-2) : 8 - 16
  • [49] Rethinking bioactivity of FLT3 inhibitors
    Fischer, Thomas
    BLOOD, 2011, 117 (12) : 3247 - 3248
  • [50] FLT3 Tyrosine Kinase Inhibitors
    Mark Levis
    Donald Small
    International Journal of Hematology, 2005, 82 : 100 - 107